Public filings / BMRN on Yahoo Finance (opens in a new tab)
BMRN: insider buying, 13F holders, analyst moves
Biomarin Pharmaceutical Inc
A summary of public filings about Biomarin Pharmaceutical Inc. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
3 of our 100 managers hold BMRN
Combined reported value $701.3M; 1 sold out since Q1 2026.
Holders among our 100 managers: 3 in Q3 2023, 3 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Viking Global Investors | $435.8M | 1.24% | Added |
| Deep Track Capital | $189.3M | 2.79% | Added |
| Deerfield Company | $76.3M | 0.80% | Added |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.